All Stories

  1. Advantages and disadvantages of peri-abortion ultrasonography
  2. Implementing a point-of-care test for β-human chorionic gonadotropin testing within an abortion service
  3. Improving Access to Medical Abortion Services: Results From Ghana and Cambodia
  4. Safety and efficacy of early medical abortion at home between 10+0 and 11+6 weeks' gestation: a retrospective review
  5. ‘Problem representations’ in post-abortion contraception: a critical review of UK literature
  6. Differences in pain, bleeding, and satisfaction during medical abortion at very early gestations
  7. The CPLAN study: Clotting Parameters after medicaL AbortioN
  8. Use of at-home sperm concentration testing in a male hormonal contraceptive efficacy clinical trial
  9. Early medical abortion before missed menses: a prospective observational study of outcomes of abortion at less than 30 days from last menstrual period
  10. How Should Physicians Manage Abortion Pain Experienced by Remote Telehealth Patients?
  11. Different doses of ibuprofen for management of pain during medical abortion: a quality improvement study
  12. The road to hormonal male contraception: End in sight?
  13. Randomized Trial of Very Early Medication Abortion
  14. Optimising Anti‐D Use: Revisiting Guidelines for First Trimester Abortions
  15. A post-abortion contraception text-and-call service to support patients to access effective contraception after telemedicine abortion
  16. Abortion patients’ perspectives on enhancing a telemedicine model of post-abortion contraception: a qualitative study
  17. No test medical abortion – a review of the evidence on selective use of preabortion testing
  18. Using telemedicine to improve early medical abortion at home (UTAH): a randomised controlled trial to compare telemedicine with in-person consultation for early medical abortion
  19. Feasibility of methadone for pain relief in first trimester abortion
  20. Very early medical abortion: treatment with mifepristone and misoprostol before ultrasonographic visualisation of an intrauterine pregnancy
  21. Medical Abortion before Confirmed Intrauterine Pregnancy: A Systematic Review
  22. PAIN management for medical abortion before 14 weeks’ gestation: A systematic review
  23. Self-reported contraceptive use and satisfaction among women accessing telemedicine medical abortion at the onset of the COVID-19 pandemic at 3–6-month follow-up
  24. Uptake of long-acting reversible contraception after telemedicine delivered abortion during Covid-19
  25. Pain management for medical abortion before 14 weeks’ gestation
  26. Views of clinicians towards providing contraceptive advice and contraception to women following early pregnancy loss: a qualitative study
  27. Mifepristone at home
  28. A qualitative study of abortion care providers’ perspectives on telemedicine medical abortion provision in the context of COVID-19
  29. How people use tablets when having a medical abortion, and what side effects they experience.
  30. Women’s experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID‐19) pandemic: a qualitative evaluation
  31. UTAH: Using Telemedicine to improve early medical Abortion at Home: a protocol for a randomised controlled trial comparing face-to-face with telephone consultations for women seeking early medical abortion
  32. Will Men Use Novel Male Contraceptive Methods and Will Women Trust Them? A Systematic Review
  33. Venus
  34. Telemedicine medical abortion at home under 12 weeks’ gestation: a prospective observational cohort study during the COVID-19 pandemic
  35. Venus
  36. Utility of a routine ultrasound for detection of ectopic pregnancies among women requesting abortion: a retrospective review
  37. Troublesome bleeding following early medical abortion
  38. Predicting human conception: the elusive ‘fertility test’
  39. Venus
  40. Venus
  41. Sexual behaviour, pregnancy intention and sexually transmitted infection risk varies extensively among transgender and non-binary patients in the UK
  42. Animations can provide information on early medical abortion
  43. Correction: Male contraception: where are we going and where have we been?
  44. High rates of treatment failure for Mycoplasma genitalium among men and women attending a sexual health clinic
  45. Male Contraception: Review of literature and future developments.
  46. Delayed presentation of uterine and bowel perforation following insertion of an intrauterine device
  47. Accuracy of a point-of-care test for quantifying human chorionic gonadotrophin (hCG) in the management of pregnancy of unknown location in an abortion service
  48. Venus
  49. Better political and legal protection to improve sex workers’ health
  50. Venus
  51. Book of Abstracts: The 15th Congress of the European Society of Contraception and Reproductive Health
  52. O30 Treatment failure in mycoplasma genitalium among gum clinic attendees
  53. P017 Managing mycoplasma genitalium in clinic: don’t forget the partners
  54. Mycoplasma genitalium: a new kid on the block
  55. O032 Implementing a test and treat pathway forMycoplasma genitaliumin men with urethritis attending a GUM clinic
  56. The moral and philosophical importance of abortion